Nicholas Stretch


Nicholas has over 25 years' experience of advising companies on all aspects of employee incentives and remuneration matters. Valued by clients for his pragmatic and commercial approach, while having an in-depth knowledge of the area, he is recognised as a leading individual practising in employee incentives by The Legal 500 and Chambers UK. Nicholas has particular experience advising life sciences companies at all stages of the life cycle, including the core tax elements.

Nicholas' life sciences experience includes advising:

  • LGC on the incentives aspects of its acquisition of the Native Antigen Company, a leading supplier of infectious disease antigens and antibodies.
  • Clinigen, a global pharmaceutical services and products company focused on providing ethical access to medicines, on the employee share and remuneration aspects of its acquisition by Triley Bidco, which valued the company at approximately £1.2 billion.
  • Antisoma, a cancer drug developer, on its employee share arrangements
  • Neuropharm, a company developing medicines for neuro-developmental disorders, on suitable share plan arrangements for executives.
  • Puricore, a company focused on its proprietary immunomodulatory technology, on various incentive arrangements and the impact of fund-raisings on its incentives.
  • Proximagen, a company focused on drug treatment for neurodegenerative disorders, on the operation of its share plans.
  • Pfizer on its acquisition of Powdermed, a company focused on the treatment of chronic infectious diseases and cancer.

He is an able and talented lawyer.". "He makes a complex area of law understandable.

Chambers UK 2022